Arthur M. Cohen & Associates, LLC Eli Lilly & CO Transaction History

Arthur M. Cohen & Associates, LLC

$551 Million
Q4 2024

A detailed history of Arthur M. Cohen & Associates, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Arthur M. Cohen & Associates, LLC holds 24,182 shares of LLY stock, worth $20.4 Million. This represents 3.39% of its overall portfolio holdings.

Number of Shares

24,182

Previous 25,473 5.07%

Holding current value

$20.4 Million

Previous $22.6 Million 17.28%

% of portfolio

3.39%

Previous 4.12%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 15, 2025	SELL	$727.2 - $932.06 $938,815 - $1.2 Million	-1,291 Reduced 5.07%	24,182 $18.7 Million
Q3 2024 Oct 30, 2024	SELL	$772.14 - $960.02 $237,046 - $294,726	-307 Reduced 1.19%	25,473 $22.6 Million
Q2 2024 Jul 29, 2024	SELL	$724.87 - $909.04 $163,095 - $204,534	-225 Reduced 0.87%	25,780 $23.3 Million
Q1 2024 Apr 22, 2024	SELL	$592.2 - $792.28 $502,185 - $671,853	-848 Reduced 3.16%	26,005 $20.2 Million
Q4 2023 Jan 10, 2024	SELL	$525.19 - $619.13 $1.21 Million - $1.43 Million	-2,309 Reduced 7.92%	26,853 $15.7 Million
Q3 2023 Oct 20, 2023	SELL	$434.7 - $599.3 $469,910 - $647,843	-1,081 Reduced 3.57%	29,162 $15.7 Million
Q2 2023 Jul 19, 2023	SELL	$350.74 - $468.98 $325,837 - $435,682	-929 Reduced 2.98%	30,243 $14.2 Million
Q1 2023 Apr 24, 2023	SELL	$310.63 - $364.82 $729,669 - $856,962	-2,349 Reduced 7.01%	31,172 $10.7 Million
Q4 2022 Jan 17, 2023	SELL	$321.55 - $374.67 $1.37 Million - $1.59 Million	-4,246 Reduced 11.24%	33,521 $0
Q3 2022 Oct 21, 2022	SELL	$296.48 - $337.87 $463,101 - $527,752	-1,562 Reduced 3.97%	37,767 $12.2 Million
Q2 2022 Jul 18, 2022	SELL	$278.73 - $327.27 $199,291 - $233,998	-715 Reduced 1.79%	39,329 $12.9 Million
Q1 2022 May 03, 2022	SELL	$234.69 - $291.66 $1.28 Million - $1.59 Million	-5,436 Reduced 11.95%	40,044 $11.5 Million
Q4 2021 Jan 24, 2022	SELL	$224.85 - $279.04 $286,683 - $355,776	-1,275 Reduced 2.73%	45,480 $12.6 Million
Q3 2021 Oct 08, 2021	SELL	$221.6 - $272.71 $54,735 - $67,359	-247 Reduced 0.53%	46,755 $10.8 Million
Q2 2021 Jul 27, 2021	BUY	$180.55 - $233.54 $3.68 Million - $4.76 Million	20,379 Added 76.55%	47,002 $10.8 Million
Q1 2021 Apr 22, 2021	SELL	$164.32 - $212.72 $3.29 Million - $4.26 Million	-20,047 Reduced 42.95%	26,623 $8.75 Million
Q3 2020 Oct 13, 2020	BUY	$146.22 - $169.13 $93,580 - $108,243	640 Added 1.39%	46,670 $6.91 Million
Q1 2020 Apr 14, 2020	SELL	$119.05 - $147.35 $38,096 - $47,152	-320 Reduced 0.69%	46,030 $6.28 Million
Q4 2019 Jan 10, 2020	SELL	$106.92 - $132.43 $195,663 - $242,346	-1,830 Reduced 3.8%	46,350 $6.09 Million
Q3 2019 Nov 04, 2019	BUY	$106.79 - $116.16 $139,574 - $151,821	1,307 Added 2.79%	48,180 $5.39 Million
Q2 2019 Jul 29, 2019	SELL	$110.79 - $129.32 $240,414 - $280,624	-2,170 Reduced 4.42%	46,873 $5.27 Million
Q1 2019 May 07, 2019	SELL	$111.31 - $131.02 $35,619 - $41,926	-320 Reduced 0.65%	49,043 $6.36 Million
Q4 2018 Feb 06, 2019	BUY	$105.9 - $118.64 $4,765 - $5,338	45 Added 0.09%	49,363 $5.71 Million
Q3 2018 Oct 22, 2018	SELL	$85.86 - $107.31 $429 - $536	-5 Reduced 0.01%	49,318 $5.29 Million
Q2 2018 Aug 13, 2018	SELL	$75.7 - $86.88 $13,247 - $15,204	-175 Reduced 0.35%	49,323 $4.21 Million
Q1 2018 Apr 23, 2018	BUY	$74.21 - $87.6 $10,018 - $11,826	135 Added 0.27%	49,498 $3.78 Million
Q4 2017 Mar 06, 2019	SELL	$81.94 - $87.89 $133,971 - $143,700	-1,635 Reduced 3.21%	49,363 $5.71 Million
Q4 2017 Jan 26, 2018	BUY	$81.94 - $87.89 $242,378 - $259,978	2,958 Added 6.16%	50,998 $4.31 Million
Q3 2014 Nov 08, 2017	BUY	N/A	48,040	48,040 $4.11 Million

Others Institutions Holding LLY

# of Institutions

4,229

Shares Held

755M

Call Options Held

9.22M

Put Options Held

10.9M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $802B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arthur M. Cohen & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arthur M. Cohen & Associates, LLC with notifications on news.

Account

Arthur M. Cohen & Associates, LLC Eli Lilly & CO Transaction History